跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确研究随机试验中的潜在剂量反应和跨组依从性假设,直接属于因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Kevin K. Dobbin
Thomas A. Louis

因果模型中对百分位不变性随机偏离的处理

研究问题
随机试验中,服药依从性与结果的关联也可能出现在安慰剂组;当跨组依从性百分位不保持不变时,如何估计潜在剂量反应曲线?
方法与思路
作者推广百分位不变性,允许个体依从性百分位在处理组与对照组之间随机置换,并基于一类随机置换模型进行近似最大似然估计。
材料陈述的贡献
摘要称,置换过程正确设定时,潜在剂量反应曲线估计表现良好,并对模型误设具有一定稳健性,从而扩展原有依从性调整方法。
阅读关注点
应核对随机置换模型如何连接两组潜在依从性、剂量反应曲线的识别条件,以及误设稳健性是在何种情形下评估的。
阅读边界
仅据所给Crossref摘要,不能判断依从性准确记录之外的完整识别条件;随机分组本身不能保证依从性相关剂量效应可识别。

原文摘要

Summary Consider a clinical trial in which participants are randomized to a single-dose treatment or a placebo control and assume that the adherence level is accurately recorded. If the treatment is effective, then good adherers in the treatment group should do better than poor adherers because they received more drug; the treatment group data follow a dose–response curve. But, good adherers to the placebo often do better than poor adherers, so the observed adherence–response in the treatment group cannot be completely attributed to the treatment. Efron and Feldman proposed an adjustment to the observed adherence–response in the treatment group by using the adherence–response in the control group. It relies on a percentile invariance assumption under which each participant’s adherence percentile within their assigned treatment group does not depend on the assigned group (active drug or placebo). The Efron and Feldman approach is valid under percentile invariance, but not necessarily under departures from it. We propose an analysis based on a generalization of percentile invariance that allows adherence percentiles to be stochastically permuted across treatment groups, using a broad class of stochastic permutation models. We show that approximate maximum likelihood estimates of the underlying dose–response curve perform well when the stochastic permutation process is correctly specified and are quite robust to model misspecification.

笔记与分组
相关领域论文